The slip
PARKINSON RECEIPTno. 9302
25 Oct 2026, 03:06 UTCdopamine neurons, braak
predictionPNMT in dopamine neurons tracks Braak Lewy-body stage
registered024c6daf6da3b943
discovery-0.05 p=0.893 n=9
replication-0.42 p=0.258 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.05, p 0.893)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa71ff3283b929c4b3850e6ab…
follows 6707f1eefe6f…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9302: PNMT in dopamine neurons, braak
- power
- full sample -0.21 (p 0.408, n 18), 95% CI -0.61 to +0.29. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.18 (p 0.471, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.18 (p 0.471, n 18). could be the mix.
- skeptic
- leave-one-out range -0.31 to -0.10, sign flips 0; without severely affected donors -0.21 (p 0.408, n 18). fragile.
- cell type
- strongest in microglia: -0.67 (p 0.0026, n 18) vs -0.21 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PNMT in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PNMT · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.28 p 0.328 (needs p < 2.3e-4)